Academic Journal

Prenatal SNP-array chromosomal microarray analysis in 3,549 pregnancies: indication-specific yields and clinical implications.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Prenatal SNP-array chromosomal microarray analysis in 3,549 pregnancies: indication-specific yields and clinical implications.
Συγγραφείς: Tao Y; Medical Genetic Center, Changzhi Maternal and Child Health Care Hospital, 38 Weiyuanmen Road, Changzhi, Shanxi, 046000, China. yltao21@163.com.; Precision Medicine Research Division, Changzhi Maternal and Child Health Care Hospital, Changzhi, Shanxi, China. yltao21@163.com., Wei Y; Medical Genetic Center, Changzhi Maternal and Child Health Care Hospital, 38 Weiyuanmen Road, Changzhi, Shanxi, 046000, China., Yao Z; Medical Genetic Center, Changzhi Maternal and Child Health Care Hospital, 38 Weiyuanmen Road, Changzhi, Shanxi, 046000, China., Han D; Medical Genetic Center, Changzhi Maternal and Child Health Care Hospital, 38 Weiyuanmen Road, Changzhi, Shanxi, 046000, China., Wang L; Department of Pediatrics, Changzhi Maternal and Child Health Care Hospital, 38 Weiyuanmen Road, Changzhi, 046000, Shanxi, China., Song W; Medical Genetic Center, Changzhi Maternal and Child Health Care Hospital, 38 Weiyuanmen Road, Changzhi, Shanxi, 046000, China., Li X; Medical Genetic Center, Changzhi Maternal and Child Health Care Hospital, 38 Weiyuanmen Road, Changzhi, Shanxi, 046000, China. Lixiaoze520@126.com.
Πηγή: BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2026 May 01; Vol. 26 (1). Date of Electronic Publication: 2026 May 01.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 100967799 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2393 (Electronic) Linking ISSN: 14712393 NLM ISO Abbreviation: BMC Pregnancy Childbirth Subsets: MEDLINE
Imprint Name(s): Original Publication: London : BioMed Central, [2001-
Ιατρικοί όροι (MeSH): Prenatal Diagnosis*/methods , Microarray Analysis*/methods , Chromosome Disorders*/diagnosis , Chromosome Disorders*/genetics , Polymorphism, Single Nucleotide*, Humans ; Female ; Pregnancy ; Retrospective Studies ; Adult ; Aneuploidy ; Advanced Maternal Age ; Ultrasonography, Prenatal ; Oligonucleotide Array Sequence Analysis ; DNA Copy Number Variations
Περίληψη: Background: SNP-based chromosomal microarray analysis (CMA) is widely used in invasive prenatal diagnosis, yet real-world performance across contemporary referral pathways, especially in the NIPT era, remains incompletely characterized.
Methods: We retrospectively analyzed 3,549 prenatal invasive samples tested by SNP array, and evaluated diagnostic yield overall and by referral indication and ultrasound phenotype.
Results: In total, we identified 398 pathogenic or likely pathogenic (P/LP) variants across 386 fetuses, resulting in an overall diagnostic yield of 10.9% (386/3,549). These findings comprised 223 aneuploidies and 175 pathogenic CNVs. In contrast, variants of uncertain significance (VOUS) were detected in 12.0% (426/3,549) of cases. Diagnostic yields were heavily stratified by indication: yields peaked in NIPT high-risk referrals (38.9%) and were intermediate in ultrasound-based cases (~ 11%), but dropped significantly in the advanced maternal age (AMA; 4.2%) and serum screening (~ 5-6%) groups. Conversely, VOUS rates remained remarkably stable across all referral categories. Sub-analysis of ultrasound abnormalities revealed that multisystem anomalies conferred the highest risk (27.3%), driven predominantly by aneuploidies; among soft markers, increased nuchal translucency (NT) emerged as the strongest predictor of chromosomal pathology.
Conclusions: In our cohort, SNP-array identified clinically actionable findings in 10.9% of cases. NIPT enriched diagnostic yields, particularly for aneuploidies, and NT thickness was strongly associated with pathogenic findings. These results support an indication-based approach to genomic testing, with NIPT as a triage tool for aneuploidy and CMA for high-risk populations, while improving VOUS counseling.
(© 2026. The Author(s).)
Competing Interests: Declarations. Ethics approval and consent to participate: This study was approved by the Clinical Research Ethics Committee of Changzhi Maternal and Child Health Care Hospital. Written informed consent was obtained from all participating pregnant women (and/or their legal guardians, where applicable). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References: Genet Med. 2020 Feb;22(2):245-257. (PMID: 31690835)
Risk Manag Healthc Policy. 2021 Apr 14;14:1533-1540. (PMID: 33889037)
Clin Chem. 2023 Jun 1;69(6):583-594. (PMID: 37022747)
Fertil Steril. 2018 Feb;109(2):201-212. (PMID: 29447663)
Hum Mutat. 2022 Aug;43(8):1031-1040. (PMID: 34694049)
J Med Genet. 2008 Aug;45(8):519-24. (PMID: 18413370)
J Womens Health (Larchmt). 2021 Feb;30(2):160-167. (PMID: 33185505)
Prenat Diagn. 2009 Oct;29(10):966-74. (PMID: 19609942)
Prenat Diagn. 2025 Sep;45(10):1359-1365. (PMID: 40326825)
Front Genet. 2023 Jun 15;14:1206855. (PMID: 37396033)
Arch Gynecol Obstet. 2024 Dec;310(6):2973-2981. (PMID: 39505749)
Eur J Hum Genet. 2021 Jan;29(1):205-215. (PMID: 32778765)
J Obstet Gynaecol. 2022 Aug;42(6):2025-2032. (PMID: 35659171)
Int J Womens Health. 2023 Nov 20;15:1791-1800. (PMID: 38020944)
Mol Cytogenet. 2023 Feb 10;16(1):3. (PMID: 36765363)
BJOG. 2021 Jan;128(2):431-438. (PMID: 32702189)
Sci Rep. 2023 May 4;13(1):7242. (PMID: 37142625)
Nature. 2024 Jan;625(7993):92-100. (PMID: 38057664)
J Med Genet. 2018 Apr;55(4):215-221. (PMID: 29496978)
Acta Obstet Gynecol Scand. 2020 Jun;99(6):775-782. (PMID: 32346853)
Front Genet. 2020 Nov 06;11:571219. (PMID: 33240322)
Sci Rep. 2019 Nov 28;9(1):17776. (PMID: 31780800)
Sci Rep. 2024 Jul 10;14(1):15920. (PMID: 38987582)
Prenat Diagn. 2017 Jun;37(6):527-539. (PMID: 28382695)
BMC Med Genomics. 2021 Dec 11;14(1):292. (PMID: 34895207)
Exp Dermatol. 2019 Oct;28(10):1156-1163. (PMID: 29672931)
Open Access Maced J Med Sci. 2019 Dec 20;7(24):4427-4431. (PMID: 32215107)
Acta Obstet Gynecol Scand. 2025 Apr;104(4):604-614. (PMID: 39611236)
Am J Obstet Gynecol. 2022 Apr;226(4):562.e1-562.e8. (PMID: 34762861)
N Engl J Med. 2012 Dec 6;367(23):2175-84. (PMID: 23215555)
Reprod Sci. 2024 Apr;31(4):1089-1107. (PMID: 38012523)
Orphanet J Rare Dis. 2024 Feb 10;19(1):56. (PMID: 38336695)
JAMA Psychiatry. 2022 Mar 01;79(3):250-259. (PMID: 35080590)
Nucleic Acids Res. 2014 Jan;42(Database issue):D986-92. (PMID: 24174537)
Prenat Diagn. 2010 Sep;30(9):893-8. (PMID: 20715120)
Pregnancy (Hoboken). 2025 Nov 18;1(6):e70139. (PMID: 42597105)
Heliyon. 2024 Oct 15;10(20):e39392. (PMID: 39502218)
Genet Med. 2024 Dec;26(12):101275. (PMID: 39310964)
Mol Genet Genomic Med. 2022 Jul;10(7):e1963. (PMID: 35535634)
Grant Information: 2021XM57 Scientific Research Foundation of the Health Commission of Shanxi Province; 202303021222374 Fundamental Research Program of Shanxi Province
Contributed Indexing: Keywords: Chromosomal microarray analysis; Copy number variants; Non-invasive prenatal testing; Prenatal diagnosis; SNP Array
Entry Date(s): Date Created: 20260501 Date Completed: 20260901 Latest Revision: 20260903
Update Code: 20260903
PubMed Central ID: PMC13531756
DOI: 10.1186/s12884-026-09187-x
PMID: 42067806
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1471-2393
DOI:10.1186/s12884-026-09187-x